FDA is evaluating risks to patients.
Health groups urge Trump to appoint Acting FDA Commissioner Ned Sharpless.
Targeted therapy gives new hope to patients with an aggressive form of lung cancer.
The new drug is an add-on to levodopa/carbidopa for Parkinson’s patients experiencing “off” episodes.
Use of these meds to treat chronic hepatitis C in patients with moderate to severe liver impairment has resulted in liver failure in rare cases.
Teva’s generic EpiPen Jr. helps alleviate allergy drug shortage.
DEA scrambles to add qualified marijuana growers.
Blockbuster drug could be key to Humira’s successor.
FDA approved the third oncology drug in the US that targets a key genetic driver of cancer, rather than a specific tumor.
While FDA’s drug approval time is generally improving, the agency needs to speed up generic drug application reviews, according to a new report.